Deepinder Goyal, co-founder of Zomato, has launched Temple, a health tech startup developing a wearable device to monitor cerebral blood flow for elite athletes. The company announced its first funding round, securing $54 million at a post-money valuation of $190 million, or roughly ₹493 crore and ₹1,700 crore respectively.
The seed round drew investments from founder friends and early Zomato backers, including Steadview Capital, Peak XV Partners, Dharana Fund, and Aaroh Fund, alongside about 80 high-net-worth individuals. Goyal is set to retain around 29% ownership post-round.
Notably, more than 30 Temple employees invested their own money in the round at the same terms as external investors, signaling strong internal alignment. Goyal highlighted this as a key indicator of team conviction.
Temple targets neuroscience-driven performance tracking, moving beyond standard fitness metrics to deliver precise brain-related insights for top athletes. The startup is actively hiring athlete-engineers, sensor specialists, and computational neuroscientists to refine its AI-powered hardware.
This move marks Goyal’s return to founding after steering Zomato through its public listing and expansion into quick commerce. Temple positions itself in India’s growing wearables market, emphasizing hardware-software integration for high-performance use cases.
